Skip to main content
HR 2623 114th Congress House Health Africa Asia Australia Canada Drug safety, medical device, and laboratory regulation Europe European Union Israel Japan New Zealand Oceania Prescription drugs South Africa Switzerland Trade restrictions

Personal Drug Importation Fairness Act of 2015

Introduced: June 3, 2015 See on congress.gov
Sign in to write a letter Sign in to watch
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jun 5, 2015
Referred to the Subcommittee on Health.
Jun 3, 2015
Referred to the House Committee on Energy and Commerce.
Jun 3, 2015
Introduced in House
 Plain-English summary Congressional Research Service

Personal Drug Importation Fairness Act of 2015

This bill allows a drug to be imported by a person other than the drug's manufacturer if the drug: (1) has the same active ingredients, route of administration, and strength as an approved drug; (2) may be lawfully marketed in, and is imported or reimported from, a country included on a list in this Act that the Food and Drug Administration determines has standards for ensuring drug safety and effectiveness that are at least as protective as U.S. standards; (3) is dispensed by a licensed pharmacist; (4) is shipped directly to, or is imported by, the ultimate consumer; (5) is shipped or imported in quantities that do not exceed a 90-day supply; (6) is accompanied by a copy of a valid prescription; and (7) is not a controlled substance.

What's happening now June 5, 2015

Referred to the Subcommittee on Health.

 Committees of jurisdiction 2
 Cosponsors 3
All 3 Democratic 3